These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15784876)

  • 1. Inhibitors of ocular neovascularization: promises and potential problems.
    van Wijngaarden P; Coster DJ; Williams KA
    JAMA; 2005 Mar; 293(12):1509-13. PubMed ID: 15784876
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-VEGF therapeutic approaches for diabetic macular edema.
    Khurana RN; Do DV; Nguyen QD
    Int Ophthalmol Clin; 2009; 49(2):109-19. PubMed ID: 19349791
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-VEGF therapy in proliferative diabetic retinopathy.
    Abdallah W; Fawzi AA
    Int Ophthalmol Clin; 2009; 49(2):95-107. PubMed ID: 19349790
    [No Abstract]   [Full Text] [Related]  

  • 4. Debate on the various anti-vascular endothelial growth factor drugs.
    Khalili MR; Hosseini H
    Indian J Ophthalmol; 2008; 56(3):255-6; author reply 256. PubMed ID: 18417837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of neovascular age-related macular degeneration with bevacizumab].
    Monzón Moreno A
    Farm Hosp; 2006; 30(6):387-8. PubMed ID: 17298199
    [No Abstract]   [Full Text] [Related]  

  • 6. [VEGF inhibitors in ophthalmology].
    Thys J; Dupont G; Rakic JM
    Rev Med Liege; 2009; 64(5-6):323-6. PubMed ID: 19642468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatments for age-related macular degeneration.
    Avery RL
    Lancet; 2007 Oct; 370(9597):1479-80; author reply 1480. PubMed ID: 17964341
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of anti-VEGF therapy in proliferative diabetic retinopathy.
    Jardeleza MS; Miller JW
    Semin Ophthalmol; 2009; 24(2):87-92. PubMed ID: 19373692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors.
    Chong V
    Ophthalmologica; 2012; 227 Suppl 1():2-10. PubMed ID: 22517120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept].
    Joussen AM
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1268-72. PubMed ID: 17541869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic therapy in neovascular age-related macular degeneration.
    Lin RC; Rosenfeld PJ
    Int Ophthalmol Clin; 2007; 47(1):117-37. PubMed ID: 17237677
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).
    Nagpal M; Nagpal K; Nagpal PN
    Indian J Ophthalmol; 2007; 55(6):437-9. PubMed ID: 17951900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging evidence concerning systemic safety of anti-VEGF agents--should ophthalmologists be concerned?
    Lim LS; Cheung CMG; Mitchell P; Wong TY
    Am J Ophthalmol; 2011 Sep; 152(3):329-331. PubMed ID: 21855670
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary.
    Giuliari GP; Guel DA; Cortez MA; Cortez RT
    Can J Ophthalmol; 2010 Oct; 45(5):501-8. PubMed ID: 20648074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracentesis before intravitreal injection of bevacizumab.
    Tsui YP; Chiang CC; Tsai YY
    Can J Ophthalmol; 2008 Apr; 43(2):239; author reply 239-40. PubMed ID: 18347632
    [No Abstract]   [Full Text] [Related]  

  • 16. Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases.
    Kaiser PK
    Am J Ophthalmol; 2006 Oct; 142(4):660-8. PubMed ID: 17011860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiangiogenic therapy].
    Arias Barquet L
    Arch Soc Esp Oftalmol; 2005 Aug; 80(8):435-6. PubMed ID: 16136393
    [No Abstract]   [Full Text] [Related]  

  • 18. [Age-related macular degeneration: therapeutic hopes].
    Behar-Cohen F; Sennlaub F; Berdugo M
    Med Sci (Paris); 2007 Feb; 23(2):127-9. PubMed ID: 17291419
    [No Abstract]   [Full Text] [Related]  

  • 19. [Introduction to the topic: anti-VEGF therapy in the management of AMD].
    Meyer CH
    Ophthalmologe; 2008 Feb; 105(2):123-4. PubMed ID: 18256843
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of diabetic retinopathy with anti-VEGF drugs.
    Waisbourd M; Goldstein M; Loewenstein A
    Acta Ophthalmol; 2011 May; 89(3):203-7. PubMed ID: 21044274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.